AngioDynamics Earnings Down $ANGO $XHS

AngioDynamics, a leading provider of medical devices for vascular access, surgery, peripheral vascular disease and oncology, has announced its third quarter results for FY-2015.

The results shows the following, Net sales of $86.6 million decreased 2% Y/Y, GAAP Net Loss per share is -$0.12 from -$0.13 Y/Y whereas EBITDS per share has improved at -$0.04 from $-0.39 Y/Y.

View the full earnings release here.